Phase I trial of split-dose induction docetaxel, cisplatin, and __number__ -fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC __number__ ).